Non-European venture investment in European biotech is on the rise
BioCentury breaks down three years of venture financings in Europe by investor geography
BioCentury breaks down three years of biotech venture financings in Europe by investor geography, company stage and round type.
European biotechs are seeing more participation by non-European investors in venture rounds than they’ve seen in the last three years, and the median size of the financings has outstripped solely domestic rounds.
BioCentury analyzed 133 European venture financings between Jan. 1, 2017 and June 30, 2020 that raised at least $25 million and found a steep rise in cross-border interest in the first half of 2020.
The question is